retatrutide news News: Lilly is fighting the FDA in court in an attempt to have the triple agonist peptide classified as a biologic. We broke down the potential strategy of Lilly on today’s podcast. Medscape | The investigational triple
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
























